Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload-Reference-Cited by-同舟云学术

Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload

Published:2012-03-07 Issue:5 Volume:88 Page:431-438
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Aydinok Yesim,Unal Sule,Oymak Yesim,Vergin Canan,Türker Zeynep D.,Yildiz Dilek,Yesilipek Akif

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2012.01769.x/fullpdf

Reference18 articles.

1. Optimizing iron chelation strategies in b-thalassaemia major;Porter;Blood Rev,2009

2. Survival and complications in patients with thalassaemia major treated with transfusion and deferoxamine;Borgna-Pignatti;Haematologica,2004

3. Growth failure and bony changes induced by deferoxamine;Olivieri;Am J Pediatr Hematol Oncol,1992

4. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies;Angelucci;Br J Haematol,1994

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?;Pediatric Blood & Cancer;2024-05-16

2. Biochemical Markers of Early Renal Dysfunction in Patients with β-thalassemia Major: A Systematic Review and Meta-analysis;Current Medicinal Chemistry;2023-10-26

3. Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study;Haematologica;2023-10-19

4. Deferasirox, an Iron-Chelating Agent, Improves Testicular Morphometric and Sperm Functional Parameters in a Rat Model of Varicocele;Oxidative Medicine and Cellular Longevity;2021-04-08

5. Clinical relevance of deferasirox trough levels in β-thalassemia patients;Clinical and Experimental Pharmacology and Physiology;2017-12-04